Endeavor BioMedicines
About:
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Website: https://www.endeavorbiomedicines.com
Top Investors: Fidelity, Invus, Perceptive Advisors, Woodline Partners, T. Rowe Price
Description:
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis. The company was founded in 2018 and is based in Solana Beach, California, United States.
Total Funding Amount:
$296M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Solana Beach, California, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)endeavorbioMedicines.com
Founders:
John Hood, Miguel de los Rios
Number of Employees:
11-50
Last Funding Date:
2024-04-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai